| Product Code: ETC10600431 | Publication Date: Apr 2025 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Thailand Human Immunodeficiency Virus Type Market Overview |
3.1 Thailand Country Macro Economic Indicators |
3.2 Thailand Human Immunodeficiency Virus Type Market Revenues & Volume, 2021 & 2031F |
3.3 Thailand Human Immunodeficiency Virus Type Market - Industry Life Cycle |
3.4 Thailand Human Immunodeficiency Virus Type Market - Porter's Five Forces |
3.5 Thailand Human Immunodeficiency Virus Type Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.6 Thailand Human Immunodeficiency Virus Type Market Revenues & Volume Share, By Medication Class, 2021 & 2031F |
3.7 Thailand Human Immunodeficiency Virus Type Market Revenues & Volume Share, By Delivery Method, 2021 & 2031F |
3.8 Thailand Human Immunodeficiency Virus Type Market Revenues & Volume Share, By Patient Group, 2021 & 2031F |
3.9 Thailand Human Immunodeficiency Virus Type Market Revenues & Volume Share, By Treatment Goals, 2021 & 2031F |
4 Thailand Human Immunodeficiency Virus Type Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness and education about HIV/AIDS |
4.2.2 Government initiatives and funding for HIV prevention and treatment programs |
4.2.3 Technological advancements in HIV testing and treatment |
4.3 Market Restraints |
4.3.1 Stigma and discrimination associated with HIV/AIDS |
4.3.2 Limited access to healthcare services in certain regions |
4.3.3 High cost of HIV medications and treatment |
5 Thailand Human Immunodeficiency Virus Type Market Trends |
6 Thailand Human Immunodeficiency Virus Type Market, By Types |
6.1 Thailand Human Immunodeficiency Virus Type Market, By Treatment Type |
6.1.1 Overview and Analysis |
6.1.2 Thailand Human Immunodeficiency Virus Type Market Revenues & Volume, By Treatment Type, 2021 - 2031F |
6.1.3 Thailand Human Immunodeficiency Virus Type Market Revenues & Volume, By Antiretroviral Therapy, 2021 - 2031F |
6.1.4 Thailand Human Immunodeficiency Virus Type Market Revenues & Volume, By Pre-exposure Prophylaxis, 2021 - 2031F |
6.1.5 Thailand Human Immunodeficiency Virus Type Market Revenues & Volume, By Post-exposure Prophylaxis, 2021 - 2031F |
6.1.6 Thailand Human Immunodeficiency Virus Type Market Revenues & Volume, By Adjuvant Therapy, 2021 - 2031F |
6.2 Thailand Human Immunodeficiency Virus Type Market, By Medication Class |
6.2.1 Overview and Analysis |
6.2.2 Thailand Human Immunodeficiency Virus Type Market Revenues & Volume, By Nucleoside Reverse Transcriptase Inhibitors, 2021 - 2031F |
6.2.3 Thailand Human Immunodeficiency Virus Type Market Revenues & Volume, By Integrase Strand Transfer Inhibitors, 2021 - 2031F |
6.2.4 Thailand Human Immunodeficiency Virus Type Market Revenues & Volume, By Protease Inhibitors, 2021 - 2031F |
6.2.5 Thailand Human Immunodeficiency Virus Type Market Revenues & Volume, By Combination Therapy, 2021 - 2031F |
6.3 Thailand Human Immunodeficiency Virus Type Market, By Delivery Method |
6.3.1 Overview and Analysis |
6.3.2 Thailand Human Immunodeficiency Virus Type Market Revenues & Volume, By Oral, 2021 - 2031F |
6.3.3 Thailand Human Immunodeficiency Virus Type Market Revenues & Volume, By Injectable, 2021 - 2031F |
6.3.4 Thailand Human Immunodeficiency Virus Type Market Revenues & Volume, By Oral, 2021 - 2031F |
6.3.5 Thailand Human Immunodeficiency Virus Type Market Revenues & Volume, By Injectable/Oral, 2021 - 2031F |
6.4 Thailand Human Immunodeficiency Virus Type Market, By Patient Group |
6.4.1 Overview and Analysis |
6.4.2 Thailand Human Immunodeficiency Virus Type Market Revenues & Volume, By HIV-Positive Adults, 2021 - 2031F |
6.4.3 Thailand Human Immunodeficiency Virus Type Market Revenues & Volume, By High-Risk Populations, 2021 - 2031F |
6.4.4 Thailand Human Immunodeficiency Virus Type Market Revenues & Volume, By Healthcare Workers, 2021 - 2031F |
6.4.5 Thailand Human Immunodeficiency Virus Type Market Revenues & Volume, By Pregnant Women, 2021 - 2031F |
6.5 Thailand Human Immunodeficiency Virus Type Market, By Treatment Goals |
6.5.1 Overview and Analysis |
6.5.2 Thailand Human Immunodeficiency Virus Type Market Revenues & Volume, By Viral Suppression, 2021 - 2031F |
6.5.3 Thailand Human Immunodeficiency Virus Type Market Revenues & Volume, By HIV Prevention, 2021 - 2031F |
6.5.4 Thailand Human Immunodeficiency Virus Type Market Revenues & Volume, By Post-Exposure Prevention, 2021 - 2031F |
6.5.5 Thailand Human Immunodeficiency Virus Type Market Revenues & Volume, By HIV-1 Transmission Prevention, 2021 - 2031F |
7 Thailand Human Immunodeficiency Virus Type Market Import-Export Trade Statistics |
7.1 Thailand Human Immunodeficiency Virus Type Market Export to Major Countries |
7.2 Thailand Human Immunodeficiency Virus Type Market Imports from Major Countries |
8 Thailand Human Immunodeficiency Virus Type Market Key Performance Indicators |
8.1 Number of individuals undergoing HIV testing annually |
8.2 Percentage of HIV-positive individuals receiving antiretroviral therapy |
8.3 Rate of new HIV infections per year |
9 Thailand Human Immunodeficiency Virus Type Market - Opportunity Assessment |
9.1 Thailand Human Immunodeficiency Virus Type Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
9.2 Thailand Human Immunodeficiency Virus Type Market Opportunity Assessment, By Medication Class, 2021 & 2031F |
9.3 Thailand Human Immunodeficiency Virus Type Market Opportunity Assessment, By Delivery Method, 2021 & 2031F |
9.4 Thailand Human Immunodeficiency Virus Type Market Opportunity Assessment, By Patient Group, 2021 & 2031F |
9.5 Thailand Human Immunodeficiency Virus Type Market Opportunity Assessment, By Treatment Goals, 2021 & 2031F |
10 Thailand Human Immunodeficiency Virus Type Market - Competitive Landscape |
10.1 Thailand Human Immunodeficiency Virus Type Market Revenue Share, By Companies, 2024 |
10.2 Thailand Human Immunodeficiency Virus Type Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here